| Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723) | 
|---|
| 07/26/2001 | WO1999064040A8 Novel polyene macrolide compounds and uses | 
| 07/19/2001 | WO2001051011A2 Condensation products of proteins, whereby azelaic acid is used | 
| 07/19/2001 | US20010008934 Stablity; useful in drugs, vaccines, personal care/cosmetics, veterinary drugs/vaccines, foods, feeds, diagnostics, cleaning agents (detergents and decontaminants); catalytic and binding components of biosensors | 
| 07/17/2001 | US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents | 
| 07/17/2001 | US6261804 Selection of proteins using RNA-protein fusions | 
| 07/12/2001 | DE10000493A1 New condensation products of proteins or protein hydrolysates with azelaic acid, are anionic emulsifiers useful in treatment of inflammation and acne and for skin whitening | 
| 07/05/2001 | WO1999064045A9 Novel therapeutic agents for membrane transporters | 
| 07/04/2001 | CN1302376A Corticotropin releasing factor receptor-1 deficient mice | 
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics | 
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors | 
| 06/13/2001 | EP1105505A2 Compound and method for the prevention and/or the treatment of allergy | 
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies | 
| 06/13/2001 | EP1105409A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components | 
| 06/13/2001 | CN1298881A Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method | 
| 06/07/2001 | WO2001040232A1 Chlorophyll and bacteriochlorophyll esters, and their preparation | 
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase | 
| 06/07/2001 | CA2392989A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them | 
| 06/06/2001 | EP1104457A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences | 
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors | 
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors | 
| 05/29/2001 | US6238892 Preferential immunoglobulin for the diagnosis and treatment of alzheimer's disease and nervous system disorders | 
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins | 
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors | 
| 05/16/2001 | CN1295668A Methods and compositions for diagnosis of hepatoma | 
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist | 
| 05/15/2001 | US6232085 Method for determining conditions that stabilize proteins | 
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors | 
| 04/25/2001 | EP0701568B1 New peptide derivatives | 
| 04/18/2001 | EP1092728A2 Biologically digestable complex of orthosilicic acid in a solid, stable and concentrated form and proces for its preparation | 
| 04/18/2001 | EP1091966A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) | 
| 04/12/2001 | WO2001025794A2 Protein fingerprinting by multisite labelling | 
| 04/12/2001 | CA2388384A1 Protein fingerprint system and related methods | 
| 04/11/2001 | EP1089749A1 Novel therapeutic agents for membrane transporters | 
| 04/11/2001 | EP1021176A4 Cobalt schiff base compounds | 
| 04/10/2001 | US6214293 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization | 
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists | 
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries | 
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries | 
| 03/28/2001 | EP1085895A1 Bradykinin antagonists | 
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists | 
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses | 
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase | 
| 03/28/2001 | EP1085890A1 Novel sodium channel drugs and uses | 
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors | 
| 03/28/2001 | EP1085888A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht 3? receptors | 
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses | 
| 03/28/2001 | EP1085879A2 Multibinding agents that modulate the 5-ht transporter | 
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors | 
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists | 
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase | 
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors | 
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein | 
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors | 
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses | 
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds | 
| 03/21/2001 | EP1083919A1 Novel antiviral compounds | 
| 03/21/2001 | EP1083918A1 Novel therapeutic agents that modulate 5-ht receptors | 
| 03/21/2001 | EP1083917A1 Novel analgesic agents | 
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors | 
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS | 
| 03/20/2001 | US6204001 Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene | 
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors | 
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds | 
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses | 
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors | 
| 03/07/2001 | CN1062909C Process for production of hydrolyzed vegetable proteins and product therefrom | 
| 03/01/2001 | WO2001014411A1 Recombinant subunit vaccine | 
| 03/01/2001 | WO2000065060A3 Dna sequence and recombinant production of a graminae allergen | 
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine | 
| 02/28/2001 | EP0672142B1 Multivalent and multispecific binding proteins, their manufacture and use | 
| 02/27/2001 | US6194543 Dendritic polypeptides | 
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors | 
| 02/20/2001 | CA2232878C Liquid detergents with ortho-substituted phenylboronic acids for inhibition of proteolytic enzymes | 
| 02/15/2001 | WO2000069900A3 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components | 
| 02/07/2001 | EP1073669A2 Gcp | 
| 02/01/2001 | WO2000058405A3 Squaraine dyes | 
| 01/24/2001 | EP1070254A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions | 
| 01/18/2001 | WO2001004316A2 Antigenic meningococcal peptides | 
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents | 
| 01/18/2001 | CA2801979A1 Antigenic meningococcal peptides | 
| 01/17/2001 | EP1068524A1 Corticotropin releasing factor receptor 1-deficient mice | 
| 01/16/2001 | CA2010800C Protein labelling | 
| 01/10/2001 | EP1067136A1 New peptide derivatives | 
| 01/03/2001 | EP1064088A1 Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates | 
| 01/03/2001 | CN1278530A Novel peptide derivative | 
| 12/14/2000 | WO2000074701A2 Method and composition for inhibiting cardiovascular cell proliferation | 
| 12/14/2000 | WO2000053749A3 Vascular adhesion molecules and modulation of their function | 
| 11/30/2000 | WO2000040700A3 Oocyte activation by sperm components | 
| 11/29/2000 | EP1055126A1 Methods and compositions for diagnosis of hepatoma | 
| 11/28/2000 | US6153589 2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents | 
| 11/23/2000 | WO2000069900A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components | 
| 11/23/2000 | CA2623458A1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components | 
| 11/23/2000 | CA2505617A1 Modified secretin and method of synthesizing thereof | 
| 11/23/2000 | CA2499211A1 Modified peptides yy and conjugates thereof | 
| 11/14/2000 | US6147275 Corticotropin releasing factor receptor 1-deficient mice | 
| 11/02/2000 | WO2000065060A2 Dna sequence and recombinant production of a graminae allergen | 
| 10/26/2000 | DE19918682A1 New recombinant DNA encoding an allergen produced by grasses of the Poaceae family, useful for diagnosis of pollen allergy and for treatment by desensitization | 
| 10/24/2000 | US6136599 Human hybrid host cell for mammalian gene expression | 
| 10/19/2000 | WO2000061813A1 A second mammalian tankyrase | 
| 10/19/2000 | CA2360318A1 A second mammalian tankyrase |